PTEN and glioblastoma: PAMAM was employed as a carrier to deliver an miR-21 inhibitor to human glioblastoma cells to investigate the chemo-sensitivity of human glioblastoma U251 (PTEN-mutant) and LN229 (PTEN wild-type) cells to taxol.